Pure Global
NCT05956106

Effect of Mulberry Fruit Powder in Metabolic Syndrome

Therapeutic Effect of Mulberry Fruit Powder Consumption in Metabolic Syndrome
University of Veterinary and Animal Sciences, Lahore - Pakistan·ClinicalTrials.gov·dietary supplementNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Metabolic Syndrome
Drug/Device/Intervention
Black Mulberry Fruit Powder
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
University of Veterinary and Animal Sciences, Lahore - Pakistan
Location
Arifwala, Pakistan
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2023
End date
Dec 01, 2023
Enrollment
40 participants
Primary outcome

Lipid profile will be assessed before and after the trial.,Fasting glucose level will be assessed before and after the trial,Weight circumference will be measured before and after the trial,Blood pressure will be assessed before and after the trial.

Summary

Metabolic syndrome is a raising concern globally, especially in developing countries such as
 Pakistan. To prevent its risk factors diet and lifestyle modification is major solution.
 Functional foods have additional benefits of treating disease while providing basic
 nutrients. Mulberry is a native fruit with the properties of functional food, it is rich in
 anthocyanin and different anti-obesity,anti-diabetic, and anti-hyperlipidemic treating
 potential antioxidants. Mulberry will prove its therapeutic potential against the risk
 factors of metabolic syndrome.

ICD-10 classifications
Metabolic disordersMetabolic disorder, unspecifiedOther metabolic disordersOther specified metabolic disordersNutritional and metabolic disorders in diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05956106
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05956106 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Veterinary and Animal Sciences, Lahore - Pakistan and is currently Not yet recruiting. The study focuses on Metabolic Syndrome. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.